CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1998 Publications

1-10  11-20

 

21. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
Bettencourt M, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW:
J Urol, 160:459-465, 1998.

 

22. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy.
Bauer JJ, Srivastava S, Connelly RR, Sesterhenn IA, Preston DM, McLeod DG, Moul JW:
Urology, 51:970-6,1998.

 

23. Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer.
Bauer JJ, Connelly RR, Sesterhenn IA, Srivastava S, McLeod DG, Moul JW:
Mil Med., 163:615-9, 1998.

 

24. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer.
Bauer JJ, Connelly RR, Sesterhenn IA, DeAusen J, Srivastava S, McLeod DG, Moul JW:
J Urol, 159(3): 929-933, 1998.